Keywords: Pharma research productivity, Thomson Reuters, R&D spending, NMEs

Global pharmaceutical R&D productivity declining, as sector relies heavily on aging portfolio; report

Article | 29 June 2010

Leading R&D-based drugmakers continue to rely heavily on sales from an aging portfolio of drugs, while the proportion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in